S
RDHL

SignatureFD’s Redhill Biopharma RDHL Stock Holding History

SignatureFD’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Hold
0
– -$2 – 3283
2023
Q2 		– Hold
0
– – – 3225
2023
Q1 		– Hold
0
– – – 3264
2022
Q4 		– Hold
0
– – – 3265
2022
Q3 		– Hold
0
– – – 3304
2022
Q2 		– Hold
0
– – – 3303
2022
Q1 		– Hold
0
– – – 3294
2021
Q4 		– Hold
0
– – – 3237
2021
Q3 		– Sell
-1
Closed -$6.78K – 2697
2021
Q2 		$5K Hold
1
– – ﹤0.01% 2296
2021
Q1 		$6K Buy
+1
New +$8.39K ﹤0.01% 2084
2020
Q4 		– Hold
0
– – – 2166
2020
Q3 		– Hold
0
– – – 2479

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SignatureFD's RDHL Position: Q3 2023 in Review

SignatureFD held its Redhill Biopharma (RDHL) position steady in Q3 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

SignatureFD first reported a position in RDHL in Q1 2021 and has held it in 2 quarters since. The position peaked at $6K in Q1 2021. 17 funds tracked by Wall St. Rank hold RDHL as of Q3 2023.

  • SignatureFD held 0 shares of Redhill Biopharma worth $0 as of Q3 2023.
  • SignatureFD left its Redhill Biopharma share count unchanged in Q3 2023.
  • Redhill Biopharma made up ﹤0.01% of SignatureFD's portfolio in Q3 2023, its #3283 holding.
  • SignatureFD first reported a position in Redhill Biopharma in Q1 2021 and has held it in 2 quarters since.
  • SignatureFD's Redhill Biopharma position peaked at $6K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2023.

Based on SignatureFD's 13F filing for Q3 2023, filed 3 Nov 2023.